A Crohn's & IBD programme at an EU clinic such as our partner Stem Plus (Sofia) is typically €3,000–€8,000 for treatment — a fraction of US or German pricing, at full European GMP standards. Some patients access treatment at no cost through one of the 89 registered Crohn's & IBD trials — see the candidacy check first.
克罗恩病和溃疡性结肠炎（炎症性肠病，IBD）涉及由对共生菌异常免疫反应和屏障功能障碍驱动的慢性肠道炎症。目前的治疗方法（5-氨基水杨酸类药物、皮质类固醇激素、生物制剂）可以抑制炎症，但不能修复潜在的粘膜缺陷或完全恢复免疫耐受。干细胞策略利用胎盘间充质干细胞（MSC）的免疫调节能力，这些细胞分泌抗炎细胞因子（IL-10、TGF-β）并促进调节性T细胞分化。MSC还通过支持紧密连接蛋白和促进粘膜愈合来增强屏障完整性。一项特别重要的进展是：darvadstrocel是一种异体MSC产品，最近获得欧盟有条件批准用于治疗复杂的肛周克罗恩病瘘管——标志着细胞疗法在IBD中首次获得监管认可。除了这个利基适应症外，全身MSC疗法用于缓解诱导和维持治疗在全球89项注册试验中处于研究阶段；其中13项正在积极招募患者。
Darvadstrocel用于肛周瘘管在欧洲医疗中心的成本约为7,000-9,500欧元/应用。全身MSC诱导疗法用于活动性克罗恩病或溃疡性结肠炎的成本为6,000-8,000欧元/输注方案。多个瘘管或联合诱导+维持方案会使成本增加至12,000-20,000欧元+/年。保险覆盖范围差异很大：欧盟批准的适应症（肛周瘘管）由多个国家医疗系统（西班牙、法国、德国）报销，需经过先期授权；全身IBD缓解疗法很少被覆盖，被列为研究性治疗。对于非瘘管适应症，自费支付是标准做法。
Darvadstrocel（Alofisel）于2018年获得欧盟有条件营销许可证，用于治疗对常规和生物疗法耐药的复杂肛周瘘管型克罗恩病。关键试验报告显示，在24周时，患者的瘘管愈合（所有治疗的瘘管无引流）发生率为50-55%，而假对照组约为30%。这是欧盟批准的唯一用于IBD的细胞疗法。对于全身诱导疗法，已发表的活动性克罗恩病或溃疡性结肠炎患者静脉MSC输注试验报告显示，在8-12周时临床缓解率为40-55%，与生物制剂诱导相当，但起效时间更长（8-12周对比TNF抑制剂的2-4周）。粘膜愈合（溃疡的内镜下消退）的实现频率低于症状缓解。长期维持数据稀少；再诱导或再输注方案正在出现。
| Location | Indicative treatment cost | Regulation |
|---|---|---|
| Bulgaria (EU) · e.g. Stem Plus | €3,000–€8,000 | EU · GMP |
| 德国 | €15,000–35,000 | EU · premium |
| USA | €18,000–35,000 | Mostly investigational |
| Serbia (e.g. Swiss Medica) | €7,000–31,000 | Non-EU |
| 墨西哥 | €3,000–12,000 | Non-EU |
| Turkey / Thailand | €5,000–18,000 | Non-EU |
Bulgaria's price reflects lower operating cost inside the same EU GMP framework as Germany — not lower quality. Cell type, number of sessions and supportive care move where a Crohn's & IBD programme sits in the €3,000–€8,000 range; you receive a fixed written quote after a medical review. The cheapest monitored route of all is a registered clinical trial — check before paying privately. Watch for hidden "cell-expansion" or repeat-cycle fees billed separately.
Lower operating cost and jurisdiction — not lower quality. Bulgaria is a full EU member, so cells are prepared to the same GMP standard as Germany, but clinic overheads and salaries are far lower. That gap, not a quality compromise, is where the saving comes from.
Cheaper is not automatically riskier — but unregulated is. The real test is GMP certification, a certified cell bank and EU oversight, which the EU provides. Be wary of ultra-low prices from clinics that will not document their laboratory or their cells.
The €3,000–€8,000 range covers the medical programme. Add flights, hotel and recovery with our calculator for your true all-in cost from your city.
A fixed written quote follows a medical review of your records — so there are no surprise charges later.
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Indicative ranges for planning, compiled from public market data; confirmed pricing follows a medical review. Not medical advice.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估